Correlation Between Amicus Therapeutics and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amicus Therapeutics and Ventyx Biosciences, you can compare the effects of market volatilities on Amicus Therapeutics and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Ventyx Biosciences.
Diversification Opportunities for Amicus Therapeutics and Ventyx Biosciences
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Amicus and Ventyx is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Amicus Therapeutics and Ventyx Biosciences
Given the investment horizon of 90 days Amicus Therapeutics is expected to generate 0.4 times more return on investment than Ventyx Biosciences. However, Amicus Therapeutics is 2.52 times less risky than Ventyx Biosciences. It trades about -0.02 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about -0.02 per unit of risk. If you would invest 1,160 in Amicus Therapeutics on September 3, 2024 and sell it today you would lose (162.00) from holding Amicus Therapeutics or give up 13.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amicus Therapeutics vs. Ventyx Biosciences
Performance |
| Timeline |
| Amicus Therapeutics |
| Ventyx Biosciences |
Amicus Therapeutics and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amicus Therapeutics and Ventyx Biosciences
The main advantage of trading using opposite Amicus Therapeutics and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.| Amicus Therapeutics vs. Incyte | Amicus Therapeutics vs. Denali Therapeutics | Amicus Therapeutics vs. argenx NV ADR | Amicus Therapeutics vs. Harmony Biosciences Holdings |
| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |